Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependentAlice O. Kamphorst, Rafi Ahmed, Andreas Wieland et al.|Science|2017Cited by 1k
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patientsAlice O. Kamphorst, Suresh S. Ramalingam, Rathi N. Pillai et al.|Proceedings of the National Academy of Sciences|2017Cited by 899
Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium ExperienceBadi El Osta, Suresh S. Ramalingam, Mark G. Kris et al.|Journal of Thoracic Oncology|2019Cited by 245
Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive AdenocarcinomaMadhusmita Behera, Gabriel Sica, Taofeek K. Owonikoko et al.|Clinical Lung Cancer|2016Cited by 94
Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancerTaofeek K. Owonikoko, Fadlo R. Khuri, Guojing Zhang et al.|Journal of Translational Medicine|2016Cited by 89